1
The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma
Condition(s):Resectable Pancreatic Ductal AdenocarcinomaLast Updated:January 18, 2018Unknown status
Metformin: 2891 Clinical Trials, Page 1 of 290
Hide Studies Not Open or Pending
2
Effect of Metformin on Carotid Atherosclerosis for Non-diabetic Patients With PsA (CAMPA Study)
Condition(s):PsA (Psoriatic Arthritis)Last Updated:August 14, 2023Not yet recruiting
3
Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
Condition(s):Glioblastoma, IDH-wildtype; Metformin; MalignanciesLast Updated:July 14, 2023Not yet recruiting
4
Metformin in Children and Adults With Fragile X Syndrome
Condition(s):Fragile X SyndromeLast Updated:February 4, 2021Completed
5
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
Condition(s):Preeclampsia; Preeclampsia Severe; High Risk Pregnancy; EclampsiaLast Updated:March 29, 2022Not yet recruiting
6
Evaluating the Efficacy and Safety of Metformin in Vitiligo
Condition(s):VitiligoLast Updated:June 2, 2023Recruiting
7
Pharmacokinetics of Metformin Intolerance
Condition(s):Diabetes Mellitus, Type 2; Metformin Adverse ReactionLast Updated:December 5, 2017Completed
8
Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice.
Condition(s):Polycystic Ovary SyndromeLast Updated:August 29, 2023Completed
9
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
Condition(s):Age-Related Macular Degeneration; Macular Degeneration, Age-Related; Dry Macular Degeneration; Geographic AtrophyLast Updated:June 9, 2023Completed
10
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
Condition(s):Osteosarcoma; Ewing SarcomaLast Updated:August 4, 2023Recruiting